| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 02/26/2003 | CN1398895A Hypoxic inducing factor-1 relative peptide and its screening |
| 02/26/2003 | CN1398869A Process of extracting tannic acid from Geranium wilfordii root and the use of the extractive |
| 02/26/2003 | CN1398620A Capsule made of hairyvein agrimonia herb, the dried rhizome of rehmannia and Chinese angelica |
| 02/26/2003 | CN1102173C Long-noded pit viper enzyme and producing process thereof |
| 02/26/2003 | CN1102044C Dragon's blood micro sponge agent and its preparing technology |
| 02/25/2003 | WO2002026233A1 Infusion of ciprofloxacin having reduced acid content and being stable in storage |
| 02/25/2003 | US6525178 PGC-1, a novel brown fat PPARgamma coactivator |
| 02/25/2003 | US6525072 Prevention and treatment of cellular disorders such as cancer |
| 02/25/2003 | US6525070 Bipiperidine derivatives as modulators of CCR3 activity and as H1 antagonists |
| 02/25/2003 | US6525067 Substituted heterocyclic derivatives |
| 02/25/2003 | US6525060 Triazolo(4,5-d)pyrimidine compounds |
| 02/25/2003 | US6525058 1-ethyl methylester 4-((3- (p-(carboxyamidino)phenyl) -2-oxo-5-oxazolidinyl)methyl)-1-piperazineacetate; Gantofiban; antagonistic action to Glycoprotein GPIIb/IIIa receptor; oily base; gantofiban citrate |
| 02/25/2003 | US6525048 Aminomethylphenoxymethyl/benzisoxazole substituted azabicyclic compounds; depression, generalized anxiety disorder, obesity, migraine; 2-(5-Fluoro-benzo(d)isoxazol-3-y)-7-(3-morpholin-4-ylmethylphenoxymethyl) -octahydro-pyrido(1,2-a)pyrazine; |
| 02/25/2003 | US6525047 Which are growth hormone secretogogues and increase the level of endogenous growth hormone; treating osteoporosis, congestive heart failure, frailty associated with aging, obesity; accelerating bone fracture repair |
| 02/25/2003 | US6524813 Novel polynucleotides and polypeptides of the spo0J family derived from Staphylococcus |
| 02/25/2003 | US6524806 Methods of screening for ligands of human hemetopoietin receptor HU-B1.219 |
| 02/25/2003 | US6524630 Use of cocoa procyanidins combined with acelylsalicyclic acid as an anti-platelet therapy |
| 02/25/2003 | CA2420556A1 Infusion of ciprofloxacin having reduced acid content and being stable on storage |
| 02/25/2003 | CA2231192C Pharmaceutical combination preparations containing erythropoietin and iron preparations |
| 02/21/2003 | WO2002016328A1 Biphenyl derivatives and the use thereof as integrin inhibitors |
| 02/21/2003 | WO2002016323A1 Biphenyl derivatives and the use thereof as integrin inhibitors |
| 02/21/2003 | CA2420208A1 Biphenyl derivatives and their use as integrin inhibitors |
| 02/21/2003 | CA2420205A1 Biphenyl derivatives and the use thereof as integrin inhibitors |
| 02/20/2003 | WO2003014703A2 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof |
| 02/20/2003 | WO2003014391A2 Method for the detection of a polymorphism in cpb2 |
| 02/20/2003 | WO2003014331A1 Erythrocytic cells and method for preserving cells |
| 02/20/2003 | WO2003014326A2 Isolation and mobilization of stem cells expressing vegfr-1 |
| 02/20/2003 | WO2003014305A2 Eukaryotic cells and method for preserving cells |
| 02/20/2003 | WO2003014294A2 Tacis and br3 polypeptides and uses thereof |
| 02/20/2003 | WO2003014145A2 Peptides that bind to atherosclerotic lesions |
| 02/20/2003 | WO2003014137A1 Adenosine a3 receptor agonists |
| 02/20/2003 | WO2003014124A1 Substituted 5,6,6a,11b-tetrahydro-7-oxa-5-aza-benzo[c]fluorene-6-carboxylic acid derivatives serving as nmda antagonists |
| 02/20/2003 | WO2003014088A1 Biphenyl thioamides serving as integrin receptor antagonists |
| 02/20/2003 | WO2003014086A1 Process for the preparation of amorphous form of torsemide |
| 02/20/2003 | WO2003014064A1 Naphthylurea and naphthylacetamide derivatives as vanilloid receptor 1 (vr1) antagonists |
| 02/20/2003 | WO2003013655A2 Carbonic anhydrase inhibitors |
| 02/20/2003 | WO2003013606A1 Thrombomodulin-containing medicinal compositions |
| 02/20/2003 | WO2003013590A1 Use of heparin-binding domain of fibronectin for diagnosis and treatment of cancer |
| 02/20/2003 | WO2003013545A1 Novel benzo-fused heterocycles as endothelin antagonisits |
| 02/20/2003 | WO2003013531A1 Phenyl derivatives as factor xa inhibitors |
| 02/20/2003 | WO2003013513A1 Stable emulsion composition |
| 02/20/2003 | WO2003013509A1 N-phenylpyrrole guanidine derivatives as melanocortin reception ligands |
| 02/20/2003 | WO2003013508A1 Therapeutic agent for depletion of an unwanted protein population from plasma |
| 02/20/2003 | WO2003013499A2 Drugs for vasculopaties |
| 02/20/2003 | WO2003013458A1 Cosmetic and/or pharmaceutical preparations containing plant extracts |
| 02/20/2003 | WO2003013442A2 Catechins for the treatment of fibrillogenesis in alzheimer's disease, parkinson's disease, systemic aa amyloidosis, and other amyloid disorders |
| 02/20/2003 | WO2003013434A2 Methods and compositions for treating diseases associated with excesses in ace |
| 02/20/2003 | WO2003013424A2 Use of r-nsaid compounds for anti-hiv treatment |
| 02/20/2003 | WO2003013423A2 Antithrombotic agent |
| 02/20/2003 | WO2002096516A8 Use of compositions comprising cyclooxygenase-2 selective inhibitors in combination with radiation for inhibition or prevention of cardiovascular disease |
| 02/20/2003 | WO2002085368A3 Use of radical scavenging compounds for treatment and prevention of no-dependent microcirculation disorders |
| 02/20/2003 | WO2002078602A3 Transdermal delivery of pergolide |
| 02/20/2003 | WO2002078564A3 Method for creating a separation of posterior cortical vitreous from the retina of the eye |
| 02/20/2003 | WO2002064026A3 Treating pulmonary disorders with gaseous agent causing repletion of gsno |
| 02/20/2003 | WO2002051351A3 Antithrombotic von willebrand factor (vwf) collagen bridging blockers |
| 02/20/2003 | WO2002049993A3 High affinity small molecule c5a receptor modulators |
| 02/20/2003 | WO2002030882A9 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses |
| 02/20/2003 | WO2002030860A9 Ketone compounds and compositions for cholesterol management and related uses |
| 02/20/2003 | WO2002026224A9 Methods and compounds for inhibiting eicosanoid metabolism and platelet aggregation |
| 02/20/2003 | WO2002022621B1 INTERPHENYLENE 7-OXABICYCLIC[2.2.1]HEPTANE OXAZOLES AS PROSTAGLANDIN F2a ANTAGONISTS |
| 02/20/2003 | US20030036637 Purification of human serum albumin |
| 02/20/2003 | US20030036568 Permeation enhancers |
| 02/20/2003 | US20030035787 Polyanhydrides with biologically active degradation products |
| 02/20/2003 | CA2456939A1 Carbonic anhydrase inhibitors |
| 02/20/2003 | CA2456744A1 Adenosine a3 receptor agonists |
| 02/20/2003 | CA2456124A1 Substituted 5,6,6a,11b-tetrahydro-7-oxa-5-aza-benzo[c]fluorene-6-carboxylic acid derivatives serving as nmda antagonists |
| 02/20/2003 | CA2455754A1 Amine derivatives |
| 02/20/2003 | CA2455336A1 Peptides that bind to atherosclerotic lesions |
| 02/20/2003 | CA2454910A1 Erythrocytic cells and method for preserving cells |
| 02/20/2003 | CA2454684A1 Eukaryotic cells and method for preserving cells |
| 02/20/2003 | CA2454417A1 Novel benzo-fused heterocycles as endothelin antagonists |
| 02/20/2003 | CA2454251A1 Isolation and mobilization of stem cells expressing vegfr-1 |
| 02/20/2003 | CA2453995A1 Tacis and br3 polypeptides and uses thereof |
| 02/20/2003 | CA2451919A1 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof |
| 02/20/2003 | CA2451691A1 Use of r-nsaid compounds for anti-hiv treatment |
| 02/19/2003 | EP1284290A1 Increase of the expression levels of factor VIII by insertion of spliceable nucleotide sequences into factor VIII cDNA |
| 02/19/2003 | EP1284265A1 Benzothiophene derivatives and medicinal use thereof |
| 02/19/2003 | EP1284141A2 Pharmaceutical combinations comprising neuronal nitric oxide synthase inhibitors for the treatment of neurodegenerative diseases |
| 02/19/2003 | EP1283886A2 Intracellular signaling proteins |
| 02/19/2003 | EP1283848A2 Protein complexes and assays for screening anti-cancer agents |
| 02/19/2003 | EP1283837A1 New thiochromane derivatives and their use as thrombin inhibitors |
| 02/19/2003 | EP1283835A2 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as protein kinase modulators |
| 02/19/2003 | EP1283828A1 Novel polymorph v of torasemide |
| 02/19/2003 | EP1283827A2 Caspase inhibitors and uses thereof |
| 02/19/2003 | EP1283823A1 Novel mmp-2/mmp-9 inhibitors |
| 02/19/2003 | EP1283723A2 Combination therapy using cox-2 selective inhibitor and thromboxane inhibitor and compositions therefor |
| 02/19/2003 | EP1283715A1 Modulaton of alpha-6 integrin-mediated responses |
| 02/19/2003 | EP1133314B1 Protein c for the treatment of sickle cell disease and thalassemia |
| 02/19/2003 | EP1131327B1 Prostaglandin conjugates for treating or preventing bone diseases |
| 02/19/2003 | EP1056749B1 NOVEL TRIAZOLO(4,5-d)PYRIMIDINE COMPOUNDS |
| 02/19/2003 | CN1398264A 吲哚－3－基衍生物 Indol-3-yl derivative |
| 02/19/2003 | CN1397564A Mutant of human tissue type plasminogen activator |
| 02/19/2003 | CN1397550A Novel benzene amine compound, its prepn. process and medicinal compsns. contg. them |
| 02/19/2003 | CN1397547A Novel benzene amine compound, its prepn. process and medicinal compsns. contg. them |
| 02/19/2003 | CN1397336A Nursing liquid for treating nutritional anemia and its preparing process |
| 02/19/2003 | CN1397324A Compound chinese medicine for treating cerebrovascular disease |
| 02/19/2003 | CN1397316A Prescription and preparing process for haemostatic 'Gonghuan' tablet |
| 02/19/2003 | CN1397282A Blood flor anendment, thrombus preventer or medicines |
| 02/18/2003 | US6521663 Aminoguanidinyl- and Alkoxyguanidinyl-substituted phenyl acetamides as protease inhibitors |
| 02/18/2003 | US6521657 Indole derivatives which are agonists of the progesterone receptor and useful for treatment of carcinoma and adenocarcinomas of uterine leiomyomata, endometriosis or polycystic ovary syndorme in a mammal |